Literature DB >> 20946285

Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: a 2-year longitudinal study.

Tsuyoshi Suzuki1, Tsuyoshi Shiga, Kazue Kuwahara, Sayaka Kobayashi, Shinichi Suzuki, Katsuji Nishimura, Atsushi Suzuki, Koichiro Ejima, Tetsuyuki Manaka, Morio Shoda, Jun Ishigooka, Hiroshi Kasanuki, Nobuhisa Hagiwara.   

Abstract

BACKGROUND: It is unclear whether depression persists in patients with implantable cardioverter defibrillators (ICDs). We evaluated the prevalence and persistence of depression in ICD patients over a 2-year period.
METHODS: The study included 90 consecutively hospitalized patients. Patients underlying heart disease was 24% coronary artery disease, 29% idiopathic dilated cardiomyopathy, 24% hypertrophic cardiomyopathy, 13% idiopathic VF/long QT syndrome and miscellaneous conditions 11%. A secondary indication for ICD implantation was present in 20 patients. All patients completed the Zung Self-Rating Depression Scale (SDS) at study baseline and at the their routine follow-up visit 2 years after the baseline questionnaire. Delivery of ICD therapies was tracked throughout the 2 years.
RESULTS: Depression, indicated by a Zung SDS index score exceeding 60, was present in 29 (32%) of patients at study baseline. Depression was present in 11/51 (21%) patients scheduled to undergo ICD implantation, 2/2 (100%) patients whose device was upgraded to a CRT-D, 3/14 (21%) patients who had undergone pulse generator replacement, 7/14 (50%) patients who experienced electrical storm and 6/9 (66%) patients hospitalized with acute decompensated heart failure. NYHA functional class III was significantly associated with depression at baseline (HR 6.7, 95% CI 1.68-27.2, p = 0.0007). No differences were noted for female gender, demographics, β-blocker use, or LVEF ≤35% (p = ns). Depression was present in 25 (28%) of patients at 2 years follow-up, persisting in 21 (72%) of patients whose Zung SDS scores were elevated at baseline. The median time from ICD shock therapy to completion of the 2 year questionnaire was 9 months (range, 1-22). Patients who were depressed (9/25, 36%) experienced more shocks than non-depressed patients (6/65, 9%) after 2 years (p = 0.002).
CONCLUSIONS: Depression is not uncommon among patients who meet criteria for ICD implantation and persists over time particularly when functional status is impaired. Depression is associated with a higher incidence shock therapy. ©2010, The Authors. Journal compilation ©2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20946285     DOI: 10.1111/j.1540-8159.2010.02887.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  11 in total

Review 1.  The distressed (Type D) personality. A risk marker for poor health outcomes in ICD patients.

Authors:  S S Pedersen; A A Schiffer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-09

2.  Perceptions of an implantable cardioverter-defibrillator: A qualitative study of families with a history of sudden life-threatening cardiac events and recommendations to improve care.

Authors:  Jarrett Linder; Nadia Hidayatallah; Marina Stolerman; Thomas V McDonald; Robert Marion; Christine Walsh; Siobhan Dolan
Journal:  Einstein J Biol Med       Date:  2013

3.  Management of Psychiatric Disorders in Patients with Cardiovascular Diseases.

Authors:  Prasad Rao Gundugurti; Ranjan Bhattacharyya; Amulya Koneru
Journal:  Indian J Psychiatry       Date:  2022-03-23       Impact factor: 2.983

4.  Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy.

Authors:  Christian Knackstedt; Marlies Arndt; Karl Mischke; Nikolaus Marx; Fred Nieman; Hanns Jürgen Kunert; Patrick Schauerte; Christine Norra
Journal:  Heart Vessels       Date:  2013-06-04       Impact factor: 2.037

5.  Medication adherence, depressive symptoms, and cardiac event-free survival in patients with heart failure.

Authors:  Jia-Rong Wu; Terry A Lennie; Rebecca L Dekker; Martha J Biddle; Debra K Moser
Journal:  J Card Fail       Date:  2013-05       Impact factor: 5.712

6.  Depression and cardiac disease: epidemiology, mechanisms, and diagnosis.

Authors:  Jeff C Huffman; Christopher M Celano; Scott R Beach; Shweta R Motiwala; James L Januzzi
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-04-07

Review 7.  Psychological effects of implantable cardioverter defibrillator shocks. A review of study methods.

Authors:  Gian Mauro Manzoni; Gianluca Castelnuovo; Angelo Compare; Francesco Pagnini; Vidal Essebag; Riccardo Proietti
Journal:  Front Psychol       Date:  2015-02-04

8.  Toward a More Efficient Implementation of Antifibrillation Pacing.

Authors:  Dan Wilson; Jeff Moehlis
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

9.  Depression and Associated Factors in Patients with Implantable Cardioverter-Defibrillators.

Authors:  Maryam Moshkani Farahani; Mehrdad Taghipour; Mohsen Motalebi; Ramezan Bakhshian; Ehsan Shahverdi; Sovaid Taghipour; Soheyla Abdi; Ramzan Moradi
Journal:  J Tehran Heart Cent       Date:  2016-10-03

10.  Depression in the context of chronic diseases in the United States and China.

Authors:  Hongjin Li; Song Ge; Brian Greene; Jacqueline Dunbar-Jacob
Journal:  Int J Nurs Sci       Date:  2018-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.